Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wenzel

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Journal of Infection Control|January 28, 2003
The case of the cold thermometersBelinda Ostrowsky, Janis Ober, Richard Wenzel, et al.
Journal of Pharmacy Practice|October 9, 2020
Cluster Headache: Opportunities for Pharmacists to Improve CareRichard Wenzel, Timothy R Smith, Alexis S Clark
American Journal of Infection Control|January 1, 2025
Response to the letter to the editor regarding "The efficacy of an alcohol-based nasal antiseptic versus mupirocin or an iodophor for preventing SSIs using a meta-analysis"Karen K Hoffmann, Connie Steed, David Kremelberg, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriersMiranda van Rijen, Marc Bonten, Richard Wenzel, et al.
American Journal of Human Genetics|February 4, 2025
Misattributed paternity discovery: A critique of medical organizations' recommendationsRichard Wenzel, Gina Daniel, Jodi Girard, et al.
Journal of Pharmacy Practice|August 13, 2014
Symptomatic Overlap and Therapeutic Opportunities in Primary HeadacheRoger Cady, Sandy Yacoub Garas, Ketu Patel, et al.
Pharmacotherapy|May 28, 2004
Migraine headache misconceptions: barriers to effective careRichard Wenzel, Marcus Dortch, Roger Cady, et al.
Advances in Therapy|August 5, 2022
Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc AnalysisJessica Ailani, Jeffrey Scott Andrews, Antje Tockhorn-Heidenreich, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene-related peptide inhibitors vs other preventive migraine treatments in the United StatesOralee J Varnado, Janna Manjelievskaia, Wenyu Ye, et al.
Patient Preference and Adherence|April 5, 2022
Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims StudyOralee J Varnado, Janna Manjelievskaia, Wenyu Ye, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Infection Control|January 28, 2003
The case of the cold thermometersBelinda Ostrowsky, Janis Ober, Richard Wenzel, et al.
Journal of Pharmacy Practice|October 9, 2020
Cluster Headache: Opportunities for Pharmacists to Improve CareRichard Wenzel, Timothy R Smith, Alexis S Clark
American Journal of Infection Control|January 1, 2025
Response to the letter to the editor regarding "The efficacy of an alcohol-based nasal antiseptic versus mupirocin or an iodophor for preventing SSIs using a meta-analysis"Karen K Hoffmann, Connie Steed, David Kremelberg, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriersMiranda van Rijen, Marc Bonten, Richard Wenzel, et al.
American Journal of Human Genetics|February 4, 2025
Misattributed paternity discovery: A critique of medical organizations' recommendationsRichard Wenzel, Gina Daniel, Jodi Girard, et al.
Journal of Pharmacy Practice|August 13, 2014
Symptomatic Overlap and Therapeutic Opportunities in Primary HeadacheRoger Cady, Sandy Yacoub Garas, Ketu Patel, et al.
Pharmacotherapy|May 28, 2004
Migraine headache misconceptions: barriers to effective careRichard Wenzel, Marcus Dortch, Roger Cady, et al.
Advances in Therapy|August 5, 2022
Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc AnalysisJessica Ailani, Jeffrey Scott Andrews, Antje Tockhorn-Heidenreich, et al.
Journal of Managed Care & Specialty Pharmacy|July 25, 2022
Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene-related peptide inhibitors vs other preventive migraine treatments in the United StatesOralee J Varnado, Janna Manjelievskaia, Wenyu Ye, et al.
Patient Preference and Adherence|April 5, 2022
Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims StudyOralee J Varnado, Janna Manjelievskaia, Wenyu Ye, et al.
Pageof 3